108 related articles for article (PubMed ID: 25367875)
1. Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer.
Haynes BP; Viale G; Galimberti V; Rotmensz N; Gibelli B; Smith IE; Dowsett M
Breast Cancer Res Treat; 2014 Nov; 148(2):327-35. PubMed ID: 25367875
[TBL] [Abstract][Full Text] [Related]
2. Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer.
Haynes BP; Viale G; Galimberti V; Rotmensz N; Gibelli B; A'Hern R; Smith IE; Dowsett M
Breast Cancer Res Treat; 2013 Feb; 138(1):157-65. PubMed ID: 23378065
[TBL] [Abstract][Full Text] [Related]
3. Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer.
Haynes BP; Ginsburg O; Gao Q; Folkerd E; Afentakis M; Buus R; Quang LH; Thi Han P; Khoa PH; Dinh NV; To TV; Clemons M; Holcombe C; Osborne C; Evans A; Skene A; Sibbering M; Rogers C; Laws S; Noor L; Smith IE; Dowsett M
NPJ Breast Cancer; 2019; 5():42. PubMed ID: 31754627
[TBL] [Abstract][Full Text] [Related]
4. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.
Ghosh MG; Thompson DA; Weigel RJ
Cancer Res; 2000 Nov; 60(22):6367-75. PubMed ID: 11103799
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
6. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
[TBL] [Abstract][Full Text] [Related]
7. Status of estrogen and progesterone receptors in various phases of the menstrual cycle in breast cancer.
Vasei M; Azarpira N; Talei A
Arch Iran Med; 2006 Jul; 9(3):250-3. PubMed ID: 16859061
[TBL] [Abstract][Full Text] [Related]
8. RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase.
Hu H; Wang J; Gupta A; Shidfar A; Branstetter D; Lee O; Ivancic D; Sullivan M; Chatterton RT; Dougall WC; Khan SA
Breast Cancer Res Treat; 2014 Aug; 146(3):515-23. PubMed ID: 25007964
[TBL] [Abstract][Full Text] [Related]
9. Menstrual cycle could affect Ki67 expression in estrogen receptor-positive breast cancer patients.
Horimoto Y; Arakawa A; Tanabe M; Kuroda K; Matsuoka J; Igari F; Himuro T; Yoshida Y; Tokuda E; Shimizu H; Hino O; Saito M
J Clin Pathol; 2015 Oct; 68(10):825-9. PubMed ID: 26060263
[TBL] [Abstract][Full Text] [Related]
10. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.
Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO
Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807
[TBL] [Abstract][Full Text] [Related]
11. Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer.
Haynes BP; Schuster G; Buus R; Alataki A; Ginsburg O; Quang LH; Han PT; Khoa PH; Van Dinh N; Van To T; Clemons M; Holcombe C; Osborne C; Evans A; Skene A; Sibbering M; Rogers C; Laws S; Noor L; Cheang MCU; Cleator SJ; Smith IE; Dowsett M
Breast Cancer Res Treat; 2021 Nov; 190(2):295-305. PubMed ID: 34524591
[TBL] [Abstract][Full Text] [Related]
12. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
[TBL] [Abstract][Full Text] [Related]
13. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
[TBL] [Abstract][Full Text] [Related]
14. The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer.
Wang Z; Dahiya S; Provencher H; Muir B; Carney E; Coser K; Shioda T; Ma XJ; Sgroi DC
Clin Cancer Res; 2007 Nov; 13(21):6327-34. PubMed ID: 17975144
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
[TBL] [Abstract][Full Text] [Related]
16. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression.
Balduzzi A; Bagnardi V; Rotmensz N; Dellapasqua S; Montagna E; Cardillo A; Viale G; Veronesi P; Intra M; Luini A; Pruneri G; Mastropasqua G; Goldhirsch A; Colleoni M
Clin Breast Cancer; 2014 Aug; 14(4):258-64. PubMed ID: 24325948
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas.
Shaw JA; Udokang K; Mosquera JM; Chauhan H; Jones JL; Walker RA
J Pathol; 2002 Dec; 198(4):450-7. PubMed ID: 12434414
[TBL] [Abstract][Full Text] [Related]
19. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
20. Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.
Van Poznak C; Cross SS; Saggese M; Hudis C; Panageas KS; Norton L; Coleman RE; Holen I
J Clin Pathol; 2006 Jan; 59(1):56-63. PubMed ID: 16394281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
